RIPK2 induces docetaxel resistance in prostate cancer through the NF-κB/P-gp signaling pathway - Shaoqiang Xing; Zhaoliang Xu; Sheng Zeng; Minghao Yue; Wenzhou Xing; Qian Liu (PLoS ONE, 2026)